Selectis Health, Inc.
Selectis Health, Inc. (GBCS) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Selectis Health, Inc. (GBCS), covering cash flow, earnings, and balance sheets.
Selectis Health, Inc. (GBCS) Income Statement & Financial Overview
Analyze Selectis Health, Inc.’s GBCS earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $10.49M | $10.40M | $10.02M | $9.59M |
| Cost of Revenue | $8.08M | $7.87M | $7.57M | $7.42M |
| Gross Profit | $2.41M | $2.53M | $2.44M | $2.17M |
| Gross Profit Ratio | $0.23 | $0.24 | $0.24 | $0.23 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $2.37M | $2.27M | $2.40M | $2.52M |
| Operating Expenses | $2.83M | $2.63M | $3.61M | $2.93M |
| Total Costs & Expenses | $10.91M | $10.50M | $11.19M | $10.35M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $542667.00 | $355717.00 | $475130.00 | $585709.00 |
| Depreciation & Amortization | $363020.00 | $362723.00 | $374118.00 | $409530.00 |
| EBITDA | $249718.00 | $141977.00 | -$798000.00 | -$354000.00 |
| EBITDA Ratio | $0.02 | $0.01 | -$0.08 | -$0.04 |
| Operating Income | -$422000.00 | -$97261.00 | -$1.17M | -$764000.00 |
| Operating Income Ratio | -$0.04 | -$0.009 | -$0.12 | -$0.08 |
| Other Income/Expenses (Net) | -$234000.00 | -$479000.00 | -$435000.00 | $1.56M |
| Income Before Tax | -$656000.00 | -$576000.00 | -$1.61M | $794344.00 |
| Income Before Tax Ratio | -$0.06 | -$0.06 | -$0.16 | $0.08 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$656000.00 | -$576000.00 | -$1.61M | $794344.00 |
| Net Income Ratio | -$0.06 | -$0.06 | -$0.16 | $0.08 |
| EPS | -$0.22 | -$0.19 | -$0.53 | $0.26 |
| Diluted EPS | -$0.22 | -$0.19 | -$0.53 | $0.26 |
| Weighted Avg Shares Outstanding | $3.07M | $3.07M | $3.07M | $3.07M |
| Weighted Avg Shares Outstanding (Diluted) | $3.07M | $3.07M | $3.07M | $3.07M |
Over the last four quarters, Selectis Health, Inc. achieved steady financial progress, growing revenue from $9.59M in Q2 2024 to $10.49M in Q1 2025. Gross profit stayed firm with margins at 23% in Q1 2025 versus 23% in Q2 2024. Operating income totaled -$422000.00 in Q1 2025, maintaining a -4% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $249718.00. Net income dropped to -$656000.00, with EPS at -$0.22. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan